Jan 09, 2017 12:31 pm UTC| Business
NEW YORK, Jan. 09, 2017 -- TG Therapeutics, Inc.(NASDAQ:TGTX) today announced that theU.S. Food and Drug Administration(FDA) has granted orphan drug designation covering the combination of TG-1101 (ublituximab), the...
Jan 09, 2017 12:31 pm UTC| Business
- Enasidenib (AG-221) NDA Submitted for IDH2m Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) - - AG-120 NDA Submission for IDH1m R/R AML Planned by Year End 2017 - - AG-348 Advancing to Pivotal Development in PK...
Jan 09, 2017 12:31 pm UTC| Business
- Enasidenib (AG-221) NDA Submitted for IDH2m Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) - - AG-120 NDA Submission for IDH1m R/R AML Planned by Year End 2017 - - AG-348 Advancing to Pivotal Development in PK...
Jan 09, 2017 12:31 pm UTC| Business
RICHMOND, Calif., Jan. 09, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, announced today that it recognized revenue from the sale of 16 Ekso GT systems in the fourth quarter ended...
Jan 09, 2017 12:31 pm UTC| Business
RICHMOND, Calif., Jan. 09, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, announced today that it recognized revenue from the sale of 16 Ekso GT systems in the fourth quarter ended...
Otonomy Provides Corporate and Product Pipeline Update
Jan 09, 2017 12:31 pm UTC| Business
SAN DIEGO, Jan. 09, 2017 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today provided an...
Otonomy Provides Corporate and Product Pipeline Update
Jan 09, 2017 12:31 pm UTC| Business
SAN DIEGO, Jan. 09, 2017 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today provided an...